A rationally designed heterojunction photocatalyst shows enhanced degradation of levofloxacin under visible light, suggesting improved photocatalytic performance.
The S-scheme In–CeO 2 /g-C 3 N 4 heterojunction achieves enhanced photocatalytic degradation of levofloxacin by preserving strong redox carriers and promoting the efficient generation of ˙OH and ˙O 2 − radicals under visible light.
No takes yet. Share an insight, caveat, or question.
Albarakati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: